DK165123C - Farmaceutisk tablet med kontrolleret afgivelse af kaliumchlorid - Google Patents

Farmaceutisk tablet med kontrolleret afgivelse af kaliumchlorid

Info

Publication number
DK165123C
DK165123C DK494986A DK494986A DK165123C DK 165123 C DK165123 C DK 165123C DK 494986 A DK494986 A DK 494986A DK 494986 A DK494986 A DK 494986A DK 165123 C DK165123 C DK 165123C
Authority
DK
Denmark
Prior art keywords
potassium chloride
controlled delivery
pharmaceutical
pharmaceutical table
delivery
Prior art date
Application number
DK494986A
Other languages
English (en)
Other versions
DK494986D0 (da
DK494986A (da
Inventor
Charles Hsiao
Chi-Tze Ku Chou
Original Assignee
Key Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Key Pharma filed Critical Key Pharma
Publication of DK494986D0 publication Critical patent/DK494986D0/da
Publication of DK494986A publication Critical patent/DK494986A/da
Application granted granted Critical
Publication of DK165123C publication Critical patent/DK165123C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubricants (AREA)
DK494986A 1985-02-19 1986-10-16 Farmaceutisk tablet med kontrolleret afgivelse af kaliumchlorid DK165123C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70271485A 1985-02-19 1985-02-19
PCT/US1986/000318 WO1986004817A1 (en) 1985-02-19 1986-02-19 Controlled release potassium chloride

Publications (3)

Publication Number Publication Date
DK494986D0 DK494986D0 (da) 1986-10-16
DK494986A DK494986A (da) 1986-10-16
DK165123C true DK165123C (da) 1993-03-01

Family

ID=24822313

Family Applications (1)

Application Number Title Priority Date Filing Date
DK494986A DK165123C (da) 1985-02-19 1986-10-16 Farmaceutisk tablet med kontrolleret afgivelse af kaliumchlorid

Country Status (13)

Country Link
EP (1) EP0211946B1 (da)
JP (1) JPH0625064B2 (da)
AU (1) AU583903B2 (da)
DE (1) DE3671373D1 (da)
DK (1) DK165123C (da)
ES (1) ES8801121A1 (da)
FI (1) FI87528C (da)
GR (1) GR860479B (da)
IE (1) IE59066B1 (da)
NZ (1) NZ215241A (da)
SG (1) SG120392G (da)
WO (1) WO1986004817A1 (da)
ZA (1) ZA861242B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704285A (en) * 1985-11-18 1987-11-03 The Dow Chemical Company Sustained release compositions comprising hydroxypropyl cellulose ethers
US4710384A (en) * 1986-07-28 1987-12-01 Avner Rotman Sustained release tablets made from microcapsules
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
GB8702411D0 (en) * 1987-02-03 1987-03-11 Zyma Sa Swellable pellets
US5009897A (en) * 1988-06-24 1991-04-23 Abbott Laboratories Pharmaceutical granules and tablets made therefrom
IE63242B1 (en) * 1988-06-24 1995-04-05 Abbott Lab Pharmaceutical granules and tablets made therefrom
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5876752A (en) * 1990-08-07 1999-03-02 Pfizer Inc. Use of interfacially-polymerized membranes in delivery devices
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
US5397574A (en) * 1993-10-04 1995-03-14 Andrx Pharmaceuticals, Inc. Controlled release potassium dosage form
US5458888A (en) * 1994-03-02 1995-10-17 Andrx Pharmaceuticals, Inc. Controlled release tablet formulation
DE69917618T2 (de) 1998-04-03 2005-06-23 Egalet A/S Zusammensetzung mit kontrollierter wirkstoff-freisetzung
WO2003024430A1 (en) 2001-09-21 2003-03-27 Egalet A/S Morphine polymer release system
EP2957281A1 (en) 2001-09-21 2015-12-23 Egalet Ltd. Polymer release system
WO2004041252A1 (en) 2002-11-08 2004-05-21 Egalet A/S Controlled release carvedilol compositions
EP2186510B1 (en) 2003-03-26 2013-07-10 Egalet Ltd. Matrix compositions for controlled delivery of drug substances
US8877241B2 (en) 2003-03-26 2014-11-04 Egalet Ltd. Morphine controlled release system
NZ580972A (en) 2007-06-04 2012-02-24 Egalet Ltd Controlled release pharmaceutical compositions for prolonged effect
WO2010089132A1 (en) 2009-02-06 2010-08-12 Egalet A/S Immediate release composition resistant to abuse by intake of alcohol
EP2445487A2 (en) 2009-06-24 2012-05-02 Egalet Ltd. Controlled release formulations
BR112015000150A2 (pt) 2012-07-06 2017-06-27 Egalet Ltd composições farmacêuticas dissuasoras de abuso de liberação controlada
FR3069545B1 (fr) * 2017-07-27 2020-10-16 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Composition d'enrobage exempte de dioxyde de titane

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4259315A (en) * 1980-06-13 1981-03-31 A. H. Robins Company, Inc. Controlled release potassium dosage form
DE3170764D1 (en) * 1980-11-12 1985-07-04 Ciba Geigy Ag Fast disaggregating pharmaceutical tablet
US4508702A (en) * 1982-06-14 1985-04-02 Key Pharmaceuticals, Inc. Sustained release aspirin
EP0111560A4 (en) * 1982-06-14 1987-02-03 Key Pharma Sustained release aspirin.
CH658188A5 (de) * 1984-03-23 1986-10-31 Ciba Geigy Ag Lagerstabile schnellzerfallende pharmazeutische presslinge.

Also Published As

Publication number Publication date
IE59066B1 (en) 1993-12-15
WO1986004817A1 (en) 1986-08-28
ES552145A0 (es) 1988-01-01
ZA861242B (en) 1986-10-29
FI864207A0 (fi) 1986-10-17
AU583903B2 (en) 1989-05-11
FI864207L (fi) 1986-10-17
EP0211946A1 (en) 1987-03-04
IE860433L (en) 1986-08-19
GR860479B (en) 1986-06-18
JPH0625064B2 (ja) 1994-04-06
NZ215241A (en) 1988-10-28
DK494986D0 (da) 1986-10-16
JPS62501845A (ja) 1987-07-23
DK494986A (da) 1986-10-16
FI87528C (fi) 1993-01-25
DE3671373D1 (de) 1990-06-28
ES8801121A1 (es) 1988-01-01
SG120392G (en) 1993-01-29
AU5514086A (en) 1986-09-10
FI87528B (fi) 1992-10-15
EP0211946B1 (en) 1990-05-23

Similar Documents

Publication Publication Date Title
DK165123C (da) Farmaceutisk tablet med kontrolleret afgivelse af kaliumchlorid
DK462486D0 (da) Farmaceutisk tablet indeholdende cefuroxim-axetil
DK409586A (da) Tablet med reguleret afgivelse samt fremgangsmaade til fremstilling deraf
DK156376C (da) Anvendelse af ibogain til fremstilling af et laegemiddel til behandling af narkotikamisbrug
DK263288D0 (da) Farmaceutisk praeparat af cefuroxim-axetil
DK162986D0 (da) Terapeutisk middel i enhedsdosisform
DK165730C (da) Sammensaetning til afgivelse af hydrofobe medikamenter og dennes fremstilling
DK546886D0 (da) Farmaceutisk praeparat
DK237187D0 (da) Farmaceutisk anvendelse af t-pa
DK162472C (da) Laegemiddelform til afgivelse af et terapeutisk middel i periodontallommen og dens omgivelser
DK361786D0 (da) Granulaere farmaceutiske praeparater med forskudt afgivelse
DK246786D0 (da) Laegemiddel indeholdende vaevs-plasminogen-aktivator
IT1214683B (it) Composizioni farmaceutiche nasali
DK166479C (da) Anvendelse af fluoxetin, norfluoxetin eller et farmaceutisk acceptabelt salt af fluoxetin eller norfluoxetin til fremstilling af et laegemiddel med anxiolytisk virkning
DK390486D0 (da) Laegemiddelpartikler med konstant frigoerelseshastighed
DK200586D0 (da) Anvendelse af pyridinonforbindelser med antithrombotisk virkning i laegemidler
DK390386A (da) Laegemiddelpartikler med konstant frigoerelseshastighed
DK599986D0 (da) Terapeutisk middel i form af et hudplaster
DK131986D0 (da) Stabilt gammainterferonpraeparat
DK259586D0 (da) Farmaceutisk tablet
DK201884D0 (da) Farmaceutisk praeparat med anti-hypertensiv virkning
DK383686A (da) Kontinuerlig fremgangsmaade til fremstilling af dimethyldialkylammoniumchlorid
IT1200467B (it) Formulazione farmaceutica
DK229789A (da) Farmaceutiske oploesninger af triamteren
DK156771C (da) Bis-dioxopiperazin-derivater med antitumor-aktivitet og laegemiddelformuleringer indeholdende saadanne forbindelser